CNN

How one new Alzheimer's drug is pushing up Medicare premiums

Written by Annette

When the US Food and Drug Administration approved a costly new drug for Alzheimer’s disease, Aduhelm, earlier this year, experts warned that all of Medicare’s more than 63 million enrollees could wind up paying the price.

Continue

About the author

Annette

Leave a Comment